Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Comment by N00bInvesT0Ron May 22, 2019 3:28pm
107 Views
Post# 29765589

RE:Mj sector always the same pattern

RE:Mj sector always the same pattern
N00bInvesT0R wrote: Big spike, big gains, sharp decline, volatility stabilizing. New crazy green wave. Major catalyst ahead for the sector = CBD fda approval Catalysts for Aphria in my opinion: -Full crop rotation - EU GMP certification (Europe market big opportunity, CC pharma not enough ;) ) - CPG CBD play in motion to pierce US markets once FDA approves! - Improvement in Q results to demonstrate it was really about using mother plants to go full crop - Center of excellence - Exposure on Bloomberg/CNBC/Midas letter Cheers!


Edit, didn't know it would be so horrible posting from my phone

Catalyst for mj sector overall : FDA approval

Catalysts for Aphria

-Full crop rotation
-Eu GMP Certification
- Have a CPG CBD play in the sleeves to unleash once FDA approves CBD
-Center of Excellence
-Q results, improvements in Aphria sales to show last Q was really about the mother plants
-Exposure from Bloomberg/CNBC/Midas letter or some known analyst like Piper setting a target!

People will probably read this and say : No Sheet Sherlock

Hopefully this time it doesn't post badly
Cheers :)

Bullboard Posts